Citation Impact
Citing Papers
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
2009 StandoutNobel
Nonpharmacological treatments for patients with Parkinson's disease
2015
Immunogenicity Risk Profile of Nanobodies
2021
New targeted probes for radioimaging of angiogenesis
2009
Decreased dopamine activity predicts relapse in methamphetamine abusers
2011
Long-term effects of exercise and physical therapy in people with Parkinson disease
2017
Parkinson disease
2017 Standout
International Parkinson and movement disorder society evidence‐based medicine review: Update on treatments for the motor symptoms of Parkinson's disease
2018
Parkinson's disease
2021 Standout
Clinical Trials of Cancer Therapies Targeting Prostate-Specific Membrane Antigen
2007
Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
2013 Standout
Exercise-induced neuroplasticity in human Parkinson's disease: What is the evidence telling us?
2015
Impulsivity, Compulsivity, and Top-Down Cognitive Control
2011 Standout
Herbal Extracts and Phytochemicals: Plant Secondary Metabolites and the Enhancement of Human Brain function
2011 Standout
Drug Addiction Endophenotypes: Impulsive Versus Sensation-Seeking Personality Traits
2010
The Beneficial Role of Intensive Exercise on Parkinson Disease Progression
2013
The recent impact of solid-phase synthesis on medicinally relevant benzoannelated nitrogen heterocycles
2002
Antibody therapy of cancer
2012 Standout
To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery
2010 Standout
Stimulant-induced dopamine increases are markedly blunted in active cocaine abusers
2014
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
2015 Standout
Stimulated Release of Size‐Selected Cargos in Succession from Mesoporous Silica Nanoparticles
2012 StandoutNobel
Efficacy of indirect dopamine agonists for psychostimulant dependence: A systematic review and meta-analysis of randomized controlled trials
2010
New developments in anti-HIV chemotherapy
2001
Antibody-Based Vascular Tumor Targeting
2009
Integrating psychological and neurobiological considerations regarding the development and maintenance of specific Internet-use disorders: An Interaction of Person-Affect-Cognition-Execution (I-PACE) model
2016 Standout
Mechanisms of drug combinations: interaction and network perspectives
2009 Standout
Physical activity and risk of Parkinson’s disease in the Swedish National March Cohort
2014
Glycotherapy: New Advances Inspire a Reemergence of Glycans in Medicine
2013 StandoutNobel
The epidemiology of Parkinson's disease: risk factors and prevention
2016 Standout
Matching chelators to radiometals for radiopharmaceuticals
2013 Standout
Behavioural addiction—A rising tide?
2015
Antibody and T‐cell responses specific for the androgen receptor in patients with prostate cancer
2007
Hormonal and neural mechanisms of food reward, eating behaviour and obesity
2014
89Zr-DFO-J591 for ImmunoPET of Prostate-Specific Membrane Antigen Expression In Vivo
2010
Parkinson Disease and Exercise
2013
Challenges of modifying disease progression in prediagnostic Parkinson's disease
2016
Therapies in Parkinsonʼs disease
2012
Immunogenicity of protein therapeutics
2007
Getting a grip on problem gambling: what can neuroscience tell us?
2014
A Bayesian model of shape and appearance for subcortical brain segmentation
2011 Standout
Within-subject template estimation for unbiased longitudinal image analysis
2012 Standout
Neurobiology of addiction: a neurocircuitry analysis
2016 Standout
Solid-Phase Synthesis of Pyrroloisoquinolines via the Intramolecular N-Acyliminium Pictet−Spengler Reaction
2005 StandoutNobel
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Solid-Phase Intramolecular N-Acyliminium Pictet−Spengler Reactions as Crossroads to Scaffold Diversity
2004 StandoutNobel
Addiction Circuitry in the Human Brain
2011
Review article: the nutritional and pharmacological consequences of obesity surgery
2014
Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy
2010
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Photoexpulsion of Surface-Grafted Ruthenium Complexes and Subsequent Release of Cytotoxic Cargos to Cancer Cells from Mesoporous Silica Nanoparticles
2013 StandoutNobel
Diagnosis and Treatment of Parkinson Disease
2020 Standout
In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism
2023 StandoutNobel
Monoclonal Antibodies for Cancer Therapy
2012 StandoutNobel
Non-fucosylated therapeutic antibodies as next-generation therapeutic antibodies
2006
Addiction: Beyond dopamine reward circuitry
2011
Stimulated Release of Size‐Selected Cargos in Succession from Mesoporous Silica Nanoparticles
2012 StandoutNobel
Specific Targeting Highly Conserved Residues in the HIV-1 Reverse Transcriptase Primer Grip Region. Design, Synthesis, and Biological Evaluation of Novel, Potent, and Broad Spectrum NNRTIs with Antiviral Activity
2005
Exercise as medicine – evidence for prescribing exercise as therapy in 26 different chronic diseases
2015 Standout
Iron-Deficiency Anemia
2015 Standout
The Interaction of Person-Affect-Cognition-Execution (I-PACE) model for addictive behaviors: Update, generalization to addictive behaviors beyond internet-use disorders, and specification of the process character of addictive behaviors
2019 Standout
Antimicrobial activity of flavonoids
2005 Standout
Treadmill training for patients with Parkinson's disease
2015
The association between lifestyle factors and Parkinson's disease progression and mortality
2019
Obesity: global epidemiology and pathogenesis
2019 Standout
Recombinant immunotoxin for cancer treatment with low immunogenicity by identification and silencing of human T-cell epitopes
2014 StandoutNobel
Works of Angelo Nacca being referenced
The humoral immune response to macrocyclic chelating agent DOTA depends on the carrier molecule.
2001
Exercise elevates dopamine D2 receptor in a mouse model of Parkinson's disease: In vivo imaging with [ 18 F]fallypride
2010
Enhancing neuroplasticity in the basal ganglia: The role of exercise in Parkinson's disease
2010
Treadmill exercise elevates striatal dopamine D2 receptor binding potential in patients with early Parkinson’s disease
2013
Striatal Dopamine D2/D3Receptor Availability Is Reduced in Methamphetamine Dependence and Is Linked to Impulsivity
2009
Orally Administered Ranitidine Plasma Concentrations before and after Biliopancreatic Diversion in Morbidly Obese Patients
1999
111In-labeled 1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid-lys(8)-vasotocin: a new powerful radioligand for oxytocin receptor-expressing tumors.
2001
Phase I Evaluation of J591 as a Vascular Targeting Agent in Progressive Solid Tumors
2007
Pyrrolobenzoxazepinone Derivatives as Non-Nucleoside HIV-1 RT Inhibitors: Further Structure−Activity Relationship Studies and Identification of More Potent Broad-Spectrum HIV-1 RT Inhibitors with Antiviral Activity
1999
Pilot Trial of Unlabeled and Indium-111–Labeled Anti–Prostate-Specific Membrane Antigen Antibody J591 for Castrate Metastatic Prostate Cancer
2005